Navigation Links
Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Date:9/24/2007

eligibility for protocol assistance and possible exemptions or reductions of certain regulatory fees during development or at the time of application for marketing approval. Once approved, the product may qualify for 10 years of marketing exclusivity in the EU.

MGCD0103 is an orally-administered, isotype-selective HDAC inhibitor. The compound is currently in two Phase I/II clinical trials, in combination with Vidaza(R) for hematological malignances and with Gemzar(R) in solid tumors; and in four Phase II monotherapy clinical trials in hematological malignancies.

About Hodgkin's Lymphoma

Hodgkin's lymphoma (HL) is a cancer of the lymphatic system that begins in the lymph nodes and progresses to other organs, including the lungs, liver, bone and bone marrow. It is characterized by the presence of Reed-Sternberg cells. Currently, there is no known cause of the disease, but epigenetic alterations including histone acetylation, have been identified. In addition, the Epstein-Barr virus, HIV and familial history are known risk factors. The disease is slightly more prevalent in men than women, and the median age of diagnosis is 38.

About MethylGene

MethylGene Inc. (TSX: MYG) is a publicly-traded biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer. The Company's lead product, MGCD0103, is an oral isotype-selective HDAC inhibitor presently in multiple clinical trials for solid tumors and hematological malignancies, including Phase II monotherapy and Phase I/II combination trials with Vidaza(R) and Gemzar(R). MGCD265 is an oral kinase inhibitor targeting the c-Met, Tie-2, Ron and VEGF receptor tyrosine kinases. In addition, MethylGene has several preclinical programs: MGCD290 an HDAC inhibitor in combination with azoles for fungal infections; an HDAC program for Huntington's disease; a sirtuins program for cancer; and a beta-lactamase program to overcome antibiotic resistance. Meth
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Dallas, Texas (PRWEB) September 23, 2014 ... report on the Global and China Isopropanol (IPA) ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:9/23/2014)...   GenoSpace , a precision medicine software company ... enable the broad use of genomic data in research ... awarded Phase I of a Fast Track Small Business ... Health (NIH) to enable enhanced data access and cohort ... During the past decade, the ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the opening of ... Central Texas footprint that includes Round Rock, Central Austin, ... the region’s most established practice will provide full service ... Kyle and San Marcos communities. , “We want ... individuals and couples living in and around South Austin,” ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black ... offers a three phase process that can lead to ... that would go far beyond anything previously imagined. First ... of healthcare.” , “Every effort to improve the quality ... discernable progress throughout that system because all of the ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2
... N.J., May 9 Barr Pharmaceuticals,Inc. (NYSE: ... Laboratories,Inc., has received final approval from the U.S. ... Drug Application (ANDA) to,manufacture and market a generic ... contraceptive product manufactured and marketed,by Bayer Schering Pharma, ...
... May 9 Genaera,Corporation (Nasdaq: GENR ) today announced ... net loss for the quarter ended March 31,2008 was $4.3 ... a net loss of $4.2 million, or $(0.24) per basic ... Genaera,s research and development expenses for the quarter ended March,31, ...
... 9 Schering-Plough,Corporation (NYSE: SGP ) will hold ... Memphis, Tenn. At 8 a.m. (CDT) (9 a.m. EDT) ... be available to all interested,parties via the corporate Web ... Fred Hassan, Chairman and CEO, will report to,shareholders on ...
Cached Biology Technology:Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3Genaera Corporation Announces First Quarter Financial Results 2Genaera Corporation Announces First Quarter Financial Results 3Genaera Corporation Announces First Quarter Financial Results 4
(Date:9/23/2014)... the effects of temperature on insects to predict how ... a Dartmouth study shows for the first time that ... ultimately limits how fast they grow. , "In other ... overall environmental conditions that shape the growth, survival and ... Lauren Culler , an Arctic postdoctoral researcher at Dartmouth. ...
(Date:9/23/2014)... scientists has identified a gene mutation that causes ... the bone marrow fails to produce normal amounts ... three generations had blood disorders, the researchers discovered ... chromosomal structures with crucial roles in normal cell ... suggest future molecular-based treatments that bypass the gene ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has ... Forecast and Opportunities, 2019" report to their offering. ... for enhancing security and protection in private as well ... The country,s government is focusing on using biometric systems ... other national IDs that are of crucial importance to ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Gene mutation discovered in blood disorder 2India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... can be swallowed like a pill, injected through a ... to screen for, detect, and potentially treat, cancer and ... size in early development stages. They will also ... researchers at McMaster University will be escalating efforts to ...
... some teenagers taking common anti-depressants may become more aggressive ... the October Behavioral Neuroscience, which is published by the ... of Texas at Austin found that juvenile hamsters given ... the United States as Prozac, became more aggressive on ...
... not be necessary in the event of a large-scale ... a study led by researchers at Fred Hutchinson Cancer ... of Infectious Diseases. , Instead, the current U.S. government ... vaccination of hospital workers and close contacts would be ...
Cached Biology News:Nano-devices hold promise for early-stage cancer detection 2Nano-devices hold promise for early-stage cancer detection 3Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 3Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 4Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 5
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
... Sensitivity Freezing Point Osmometer for 10 ... volume applications, including pediatric, neonatal, geriatric, ... Automatic Calibration with 2 or ... printer, keypad and software for statistical ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: